BACKGROUND: Cancers in the proximal colon, distal colon, and rectum are frequently studied together; however, there are biological differences in cancers across these sites, particularly in the prevalence of microsatellite instability. OBJECTIVE: We assessed the differences in survival by colon or rectal cancer site, considering the contribution of microsatellite instability to such differences. DESIGN: This is a population-based prospective cohort study for cancer survival. SETTINGS: This study was conducted within the Colon Cancer Family Registry, an international consortium. Participants were identified from population-based cancer registries in the United States, Canada, and Australia. PATIENTS: Information on tumor site, microsatellite instability, and survival after diagnosis was available for 3284 men and women diagnosed with incident invasive colon or rectal cancer between 1997 and 2002, with ages at diagnosis ranging from 18 to 74. MAIN OUTCOME MEASURES: Cox regression was used to calculate hazard ratios for the association between all-cause mortality and tumor location, overall and by microsatellite instability status. RESULTS: Distal colon (HR, 0.59; 95% CI, 0.49-0.71) and rectal cancers (HR, 0.68; 95% CI, 0.57-0.81) were associated with lower mortality than proximal colon cancer overall. Compared specifically with patients with proximal colon cancer exhibiting no/low microsatellite instability, patients with distal colon and rectal cancers experienced lower mortality, regardless of microsatellite instability status; patients with proximal colon cancer exhibiting high microsatellite instability had the lowest mortality. LIMITATIONS: Study limitations include the absence of stage at diagnosis and cause-of-death information for all but a subset of study participants. Some patient groups defined jointly by tumor site and microsatellite instability status are subject to small numbers. CONCLUSION: Proximal colon cancer survival differs from survival for distal colon and rectal cancer in a manner apparently dependent on microsatellite instability status. These findings support the premise that proximal colon, distal colon, and rectal cancers are clinicopathologically distinct.
BACKGROUND:Cancers in the proximal colon, distal colon, and rectum are frequently studied together; however, there are biological differences in cancers across these sites, particularly in the prevalence of microsatellite instability. OBJECTIVE: We assessed the differences in survival by colon or rectal cancer site, considering the contribution of microsatellite instability to such differences. DESIGN: This is a population-based prospective cohort study for cancer survival. SETTINGS: This study was conducted within the Colon Cancer Family Registry, an international consortium. Participants were identified from population-based cancer registries in the United States, Canada, and Australia. PATIENTS: Information on tumor site, microsatellite instability, and survival after diagnosis was available for 3284 men and women diagnosed with incident invasive colon or rectal cancer between 1997 and 2002, with ages at diagnosis ranging from 18 to 74. MAIN OUTCOME MEASURES: Cox regression was used to calculate hazard ratios for the association between all-cause mortality and tumor location, overall and by microsatellite instability status. RESULTS: Distal colon (HR, 0.59; 95% CI, 0.49-0.71) and rectal cancers (HR, 0.68; 95% CI, 0.57-0.81) were associated with lower mortality than proximal colon cancer overall. Compared specifically with patients with proximal colon cancer exhibiting no/low microsatellite instability, patients with distal colon and rectal cancers experienced lower mortality, regardless of microsatellite instability status; patients with proximal colon cancer exhibiting high microsatellite instability had the lowest mortality. LIMITATIONS: Study limitations include the absence of stage at diagnosis and cause-of-death information for all but a subset of study participants. Some patient groups defined jointly by tumor site and microsatellite instability status are subject to small numbers. CONCLUSION:Proximal colon cancer survival differs from survival for distal colon and rectal cancer in a manner apparently dependent on microsatellite instability status. These findings support the premise that proximal colon, distal colon, and rectal cancers are clinicopathologically distinct.
Authors: George P Kim; Linda H Colangelo; H Samuel Wieand; Soonmyung Paik; Ilan R Kirsch; Norman Wolmark; Carmen J Allegra Journal: J Clin Oncol Date: 2007-01-16 Impact factor: 44.544
Authors: Frank A Sinicrope; Rafaela L Rego; Kevin C Halling; Nathan Foster; Daniel J Sargent; Betsy La Plant; Amy J French; John A Laurie; Richard M Goldberg; Stephen N Thibodeau; Thomas E Witzig Journal: Gastroenterology Date: 2006-09 Impact factor: 22.682
Authors: Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-11-02 Impact factor: 4.254
Authors: Robert A Meguid; Mark B Slidell; Christopher L Wolfgang; David C Chang; Nita Ahuja Journal: Ann Surg Oncol Date: 2008-07-12 Impact factor: 5.344
Authors: Guoren Deng; Sanjay Kakar; Hirofumi Tanaka; Koji Matsuzaki; Soichiro Miura; Marvin H Sleisenger; Young S Kim Journal: Eur J Cancer Date: 2008-05-15 Impact factor: 9.162
Authors: Paul J Limburg; Robert A Vierkant; James R Cerhan; Ping Yang; Deann Lazovich; John D Potter; Thomas A Sellers Journal: Clin Gastroenterol Hepatol Date: 2003-05 Impact factor: 11.382
Authors: Nicole de Rosa; Miguel A Rodriguez-Bigas; George J Chang; Jula Veerapong; Ester Borras; Sunil Krishnan; Brian Bednarski; Craig A Messick; John M Skibber; Barry W Feig; Patrick M Lynch; Eduardo Vilar; Y Nancy You Journal: J Clin Oncol Date: 2016-07-18 Impact factor: 44.544
Authors: Sheetal Hardikar; Polly A Newcomb; Peter T Campbell; Aung Ko Win; Noralane M Lindor; Daniel D Buchanan; Karen W Makar; Mark A Jenkins; John D Potter; Amanda I Phipps Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-05-14 Impact factor: 4.254
Authors: Alexander T Sougiannis; Brandon VanderVeen; Ioulia Chatzistamou; Jason L Kubinak; Mitzi Nagarkatti; Daping Fan; E Angela Murphy Journal: Am J Physiol Gastrointest Liver Physiol Date: 2022-01-12 Impact factor: 4.052
Authors: Paul Lochhead; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Kana Wu; Reiko Nishihara; Michael O'Brien; Shuji Ogino Journal: Am J Gastroenterol Date: 2014-06-17 Impact factor: 10.864
Authors: Amanda I Phipps; Dennis J Ahnen; Peter T Campbell; Aung Ko Win; Mark A Jenkins; Noralane M Lindor; Robert Gryfe; John D Potter; Polly A Newcomb Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-02 Impact factor: 4.254
Authors: Russell Bonneville; Melanie A Krook; Esko A Kautto; Jharna Miya; Michele R Wing; Hui-Zi Chen; Julie W Reeser; Lianbo Yu; Sameek Roychowdhury Journal: JCO Precis Oncol Date: 2017-10-03